Pharma News

CB-11 by Cellebrain for Glioblastoma Multiforme (GBM): Likelihood of Approval

CB-11 is under clinical development by Cellebrain and currently in Phase I for Glioblastoma Multiforme (GBM).

Source link
#CB11 #Cellebrain #Glioblastoma #Multiforme #GBM #Likelihood #Approval

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *